RET inhibitor for use in treating cancer having a RET alteration Grant US-11872192-B2 United States of America 16 Jan 2024
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION Grant EP-3773589-B1 European Patent Office 01 Nov 2023
USE OF STEM CELL EXOSOMES FOR TREATING OVERACTIVE BLADDER Application US-20220047638-A1 United States of America 17 Feb 2022
COMBINED USE OF SQUIRREL POXVIRUS AND MYXOMA POXVIRUS, FOR TREATING CANCER Application US-20210169957-A1 United States of America 10 Jun 2021